Topics:
Radiation Oncology • Genitourinary Cancers
How do you choose between moderate hypofractionation vs SBRT for intact low or intermediate risk prostate cancer patients?
Are there clinical factors that go into your decision making?
Answer from: Radiation Oncologist at Academic Institution
In low risk prostate cancer patients, hypofractionated regimens have been proven to be equivalent to standard fractionation in randomized studies (e.g. RTOG 0415 - PMID: 27044935) . Mulitiple non-randomized studies have shown that SBRT appears to have comparable results to historical controls of sta...
Sign in or Register to read more